Sangamo Therapeutics
SGMO
#8887
Rank
S$0.18 B
Marketcap
S$0.55
Share price
-6.56%
Change (1 day)
-82.99%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of September 2025 : S$37.99 Million

According to Sangamo Therapeutics 's latest financial reports the company has S$37.99 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$56.97 M-46.74%
2023-12-31S$0.10 B-71.26%
2022-12-31S$0.37 B-26.89%
2021-12-31S$0.50 B-40.01%
2020-12-31S$0.84 B73.64%
2019-12-31S$0.48 B-10.6%
2018-12-31S$0.54 B67.98%
2017-12-31S$0.32 B57.75%
2016-12-31S$0.20 B-30.22%
2015-12-31S$0.29 B25.02%
2014-12-31S$0.23 B101.09%
2013-12-31S$0.11 B51.32%
2012-12-31S$77.71 M-28.68%
2011-12-31S$0.10 B40.31%
2010-12-31S$77.65 M-34.88%
2009-12-31S$0.11 B28.62%
2008-12-31S$92.71 M-20.54%
2007-12-31S$0.11 B41.13%
2006-12-31S$82.68 M5.75%
2005-12-31S$78.18 M44.09%
2004-12-31S$54.26 M-27.18%
2003-12-31S$74.5 M-17.65%
2002-12-31S$90.47 M-20.65%
2001-12-31S$0.11 B3.59%
2000-12-31S$0.11 B769.86%
1999-12-31S$12.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
S$9.42 B 24,714.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$3.49 B 9,099.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.11 B 31,791.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$5.08 B 13,272.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$5.91 B 15,462.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$23.81 B 62,575.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.89 B 4,890.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.36 B 61,400.54%๐Ÿ‡บ๐Ÿ‡ธ USA